Maturity onset diabetes of the young due to HNF1A variants in Croatia

Maturity onset diabetes of the young due to mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults. It is often misdiagnosed as type 1 or type 2 diabetes, but establishing genetic diagnosis is important, as treatment differs from the common types of diabetes. HNF1A-MODY has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemia Medica 2018-06, Vol.28 (2), p.020703-020703
Hauptverfasser: Pavić, Tamara, Juszczak, Agata, Pape Medvidović, Edita, Burrows, Carla, Šekerija, Mario, Bennett, Amanda J, Ćuća Knežević, Jadranka, Gloyn, Anna L, Lauc, Gordan, McCarthy, Mark I, Gornik, Olga, Owen, Katharine R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Maturity onset diabetes of the young due to mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults. It is often misdiagnosed as type 1 or type 2 diabetes, but establishing genetic diagnosis is important, as treatment differs from the common types of diabetes. HNF1A-MODY has not been investigated in Croatia before due to limited access to genetic testing. In this study we aimed to describe the characteristics of young adults diagnosed with diabetes before the age of 45 years, who have rare allele variants, and estimate the prevalence of HNF1A-MODY in Croatia. We recruited 477 C-peptide positive and beta cell antibody negative subjects through the Croatian Diabetes Registry. was sequenced for all participants and systematic assessment of the variants found was performed. The prevalence of HNF1A-MODY was calculated in the study group and results extrapolated to estimate the proportion of diabetic individuals with HNF1A-MODY in Croatia and the population prevalence. Our study identified 13 individuals harbouring rare allelic variants. After systematic assessment, 8 were assigned a diagnosis of HNF1A-MODY. Two individuals were able to discontinue insulin treatment following the diagnosis. We estimated that HNF1A-MODY in Croatia has a prevalence of 66 (95% CI 61 - 72) cases million. The estimated prevalence of HNF1A-MODY in Croatia is similar to that reported in other European countries. Finding cases lead to important treatment changes for patients. This strongly supports the introduction of diagnostic genetic testing for monogenic diabetes in Croatia.
ISSN:1330-0962
1846-7482
DOI:10.11613/BM.2018.020703